Microsclerotherapy as a modality of treatment in superficial venous malformations

Farid Ahmad Khan, Khalil Al Nakib, Abdul Rehman Awf Quaba

Abstract


Venous malformation is a difficult clinical problem with a wide spectrum. There is a continuum of localized venous malformations from blue telangiectatic capillaries through spongy blebs, through cavernous lesions to diffuse venous ectasias. Apart from cosmetic concern majority of localized superficial venous malformations are asymptomatic and managed by explanation and reassurance. With the advent of laser therapy patients with this distinct group of superficial flat venous malformations were referred to our laser suite. Response to laser therapy was poor because of large diameter of the abnormal vessels. Microsclerotherapy, an established method of treatment of lower limb telangiectasias, was tried on twenty five patients with localized superficial malformations. The outcome was satisfactory indicating that microsclerotherapy can be used safely as an effective modality of treatment for superficial malformations.  


Keywords


Microsclerotherapy, venous malformation

Full Text:

PDF

References


Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104: 1-9.

Georgantopoulou AA, Al-Nakib K, Quaba AA.Treatment of arborising telangiectasia with pulsed tunable dye laser. Br J Plast Surg 1999; 51: 614-20.

Quaba AA. Telangiectasia. Is treatment worthwhile and who should pay? In: Ruckley V, ed. Epidemiology, management and delivery of care for venous disease. 1st edn. London: Springer-Verlag; 1999.

Imhoff E, Stemmer R. Classification and mechanism of sclerosing agents. Soc Franc Phlebol 1969; 22: 143-5.

Sadik NS. Sclerotherapy of varicose and telangiectatic leg veins: Minimal sclerosing agent concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991; 17: 65-9.

Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: A histologic evaluation. J Dermatol Surg Oncol; 13: 547-51.

Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1991; 17: 75-9.

Goldman MP, Fitzpatrick RE, eds. Sclerotherapy as treatment of vericose and telengiactatic leg vein., 1st edn. New York: Mosby; 1995.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014